Natural Killer Cell Function is Well Preserved in Asymptomatic Human Immunodeficiency Virus Type 2 (HIV-2) Infection but Similar to That of HIV-1 Infection when CD4 T-cell Counts Fall
Overview
Affiliations
Natural killer (NK) cells are potent effectors of natural immunity and their activity prevents human immunodeficiency virus type 1 (HIV-1) viral entry and viral replication. We sought to determine whether NK immune responses are associated with different clinical course of HIV-1 and HIV-2 infections. A cross-sectional analysis of NK cell responses was undertaken in 30 HIV-1 and 30 HIV-2 subjects in each of three categories of CD4(+)-T-cell counts (>500, 200 to 500, and <200 cells/microl) and in 50 HIV-uninfected control subjects. Lytic activity and gamma interferon (IFN-gamma) secretion were measured by chromium release and enzyme-linked immunospot assays, respectively. Flow cytometry was used to assess intracellular cytokines and chemokines. Levels of NK cytotoxicity were significantly higher in HIV-2 than in HIV-1 infections in subjects with high CD4(+)-T-cell counts and were similar to that of the healthy controls. In these HIV-2 subjects, cytolytic activity was positively correlated to NK cell count and inversely related to plasma viremia. Levels of intracellular MIP-1beta, RANTES, tumor necrosis factor alpha, and IFN-gamma produced by NK CD56(bright) cells were significantly higher in HIV-2- than HIV-1-infected subjects with high CD4(+)-T-cell counts but fell to similar levels as CD4 counts dropped. The data suggest efficient cytolytic and chemokine-suppressive activity of NK cells early in HIV-2 infection, which is associated with high CD4(+) T-cell counts. Enhancement of these functions may be important in immune-based therapy to control HIV disease.
Gill J, Bansal B, Guo K, Huang F, Singh H, Hur J Int J Mol Sci. 2024; 25(11).
PMID: 38892421 PMC: 11173216. DOI: 10.3390/ijms25116235.
Ponnan S, Vidyavijayan K, Thiruvengadam K, J N, Mathayan M, Murugavel K Front Immunol. 2021; 12:666388.
PMID: 33936106 PMC: 8085399. DOI: 10.3389/fimmu.2021.666388.
Conventional Dendritic Cells and Slan Monocytes During HIV-2 Infection.
Iannetta M, Isnard S, Manuzak J, Guillerme J, Notin M, Bailly K Front Immunol. 2020; 11:1658.
PMID: 32903610 PMC: 7438582. DOI: 10.3389/fimmu.2020.01658.
HIV-2 as a model to identify a functional HIV cure.
Esbjornsson J, Jansson M, Jespersen S, Mansson F, Honge B, Lindman J AIDS Res Ther. 2019; 16(1):24.
PMID: 31484562 PMC: 6727498. DOI: 10.1186/s12981-019-0239-x.
Samri A, Charpentier C, Diallo M, Bertine M, Even S, Morin V PLoS Pathog. 2019; 15(5):e1007758.
PMID: 31095640 PMC: 6541300. DOI: 10.1371/journal.ppat.1007758.